Supernus Pharmaceuticals | Resultado Líquido



Net Income Alterar Data
Abbott USD 1.33B 7.9B 2025-03
ANI Pharmaceuticals USD -10276000 13.89M 2024-12
Aurora Cannabis CAD 31.67M 43.71M 2024-12
Bristol-Myers Squibb USD 72M 1.14B 2024-12
Canopy Growth CAD -121896000 6.4M 2024-12
Corcept Therapeutics USD 30.75M 16.47M 2024-12
Eisai JPY 23.79B 12.68B 2024-12
Eli Lilly USD 4.41B 3.44B 2024-12
Indivior 4M 111M 2024-09
Novo Nordisk 27.3B 7.25B 2024-09
Pacira USD 16.04M 159.51M 2024-12
Perrigo USD -44500000 23.5M 2024-12
Pfizer USD 410M 4.06B 2024-12
Supernus Pharmaceuticals USD 15.33M 23.17M 2024-12
United Therapeutics USD 301.3M 7.8M 2024-12
Xeris Pharmaceuticals USD -54836000 39.1M 2024-12



Supernus Pharmaceuticals Resultado Líquido - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Apr 2025.